Erenumab Effective, Safe for Rosacea-Linked Erythema, Flushing

WEDNESDAY, April 17, 2024 -- The anticalcitonin gene-related peptide-receptor monoclonal antibody erenumab is effective and safe for treatment of rosacea-associated erythema and flushing, according to a study published online April 17 in JAMA...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news